Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral th
about
Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral th
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Telmisartan and Insulin Resist ...... combination antiretroviral th
@en
Telmisartan and Insulin Resist ...... combination antiretroviral th
@nl
type
label
Telmisartan and Insulin Resist ...... combination antiretroviral th
@en
Telmisartan and Insulin Resist ...... combination antiretroviral th
@nl
prefLabel
Telmisartan and Insulin Resist ...... combination antiretroviral th
@en
Telmisartan and Insulin Resist ...... combination antiretroviral th
@nl
P2093
P2860
P50
P1433
P1476
Telmisartan and Insulin Resist ...... ination antiretroviral therapy
@en
P2093
Catherine Spowart
Claire Taylor
Jiten Vora
John Whitehead
Marta García-Fiñana
Paula Williamson
Ruwanthi Kolamunnage-Dona
Thomas Jaki
P2860
P304
P356
10.1136/BMJOPEN-2015-009566
P407
P577
2015-10-15T00:00:00Z